Description
Tumores neuroendocrinos gastroenteropancreáticos
Administrar con alimentos para asegurar una adecuada absorción
Cada comprimido contiene 400 mg de raltegravir
PRINCIPIO ACTIVO: LORATADINA
PRINCIPIO ACTIVO: HIERRO
CUTIVATE 0.05 G 30 G CRA FORMULA LACTEA 900.00 MG Tumores neuroendocrinos gastroenteropancreáticosSUSTANCIA: CUTIVATE CMA. 0. 05 G. CAJA C TUBO C 30 G. FABRICANTE: GLAXO SMITH KLINE
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
